About

Our Heritage

Vision, Mission & Values

Facts & Figures

Governance

Quality

Research & Development

Regulatory Support

ESG and sustainability

SG Steps

Whistleblowing

Fishers Plant (Indiana) USA

 Careers Investors
Point-of-care diagnostic devices - Stevanato Group
Stevanato Group develops, produces and assembles Point of Care devices, including lancing systems and glucose monitoring devices. Learn more about our Point-of-care diagnostic devices!
Home - Managing Complexity, Delivering Value - Stevanato Group > Products & Capabilities - Stevanato Group > In-Vitro Diagnostics and Medical Solutions - Stevanato Group > Point-of-care diagnostic devices - Stevanato Group
page-wrapper
...

Point of Care Devices

We develop, produce and assemble Point of Care devices, including lancing systems and glucose monitoring devices

Our extensive expertise in point-of-care devices tailored to the patient unique needs

With our extensive experience in R&D, industrialization, molding, and manual as well as automatic assembly, Stevanato Group has grown into a perfect integrated solution provider for point-of-care testing solutions. The group combines extensive knowledge of analytics, plastic molding and scalable equipment solutions for the automatic assembly of devices. We are the ideal partner for advanced self-application devices – supporting you from the initial concept creation all the way through to industrialization.

Test Segments
282 Insulin Test

Glucose Monitoring

235 Diabetes

Hematology

85 Diagnostic

Molecular Diagnostic

236 Monoclonal Antibodies

Immuno Assay

335_toxicologic test

Clinical Chemistry

199 Chemical Molecule

Drug Testing

349_Asthma

Breath Sampling and more

Case Study

The Challenge

A German company required the development of a point-of-care testing device, including building manual, semi-automatic, and fully automatic assembly of housing, PCB, display, and keypad. These had to meet stringent IVDR requirements throughout the project, from concept to industrialization.

Our Added Value

  • Combining our CDMO know-how with years of experience in high-precision molding and in the scaling up of production using fully automatic assembly lines.​
  • The complexity and needs of such a project required a first production lots for testing and initial launch being produced using benchtop equipment, subsequently moving to semi-automatic lines and finally to fully automatic assembly lines.​
  • DFA (Design for Assembly) played a crucial role from the beginning, while learnings from the manual assembly were equally important as input for the automation.​
  • Volume assembly lines included functionality testing of the device and final assembly (wet assembly) and packaging steps.
Interested in Point-of-Care Devices?
Submit your request